Citius Oncology (CTOR) Stock Price, News & Analysis

Company Overview

TenX Keane Acquisition Corp. is a blank check company. It formed for the purpose to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. TenX Keane Acquisition Corp. is based in New York.

Key Stats

• Today's Range: $1.56 to $1.65
• 50-Day Range: N/A
• 52-Week Range: $1.53 to $49.00
• Volume: 39,250 shs
• Average Volume: 112,110 shs
• Market Capitalization: $3.71 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CTOR Stock Analysis - Frequently Asked Questions

How have CTOR shares performed this year?

Citius Oncology's stock was trading at $2.47 at the start of the year. Since then, CTOR stock has decreased by 36.4% and is now trading at $1.57.
View the best growth stocks for 2024 here.

How do I buy shares of Citius Oncology?

Shares of CTOR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

• Today: 9/19/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Holding & other investment offices
• Sub-Industry: N/A
• Current Symbol: NASDAQ:CTOR
• CUSIP: N/A
• CIK: 1851484
• Web: N/A
• Phone: 347-627-0058
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 2,360,000
• Free Float: N/A
• Market Cap: $3.71 million
• Optionable: N/A
• Beta: -0.09